Atrial fibrillation (AF) is the most common form of sustained clinical arrhythmia. We previously mapped an AF locus to chromosome 5p13 in an AF family with sudden death in early childhood. Here we show that the specific AF gene underlying this linkage is NUP155, which encodes a member of the nucleoporins, the components of the nuclear pore complex (NPC). We have identified a homozygous mutation, R391H, in NUP155 that cosegregates with AF, affects nuclear localization of NUP155, and reduces nuclear envelope permeability. Homozygous NUP155 À/À knockout mice die before E8.5, but heterozygous NUP155 +/À mice show the AF phenotype. The R391H mutation and reduction of NUP155 are associated with inhibition of both export of Hsp70 mRNA and nuclear import of Hsp70 protein. These human and mouse studies indicate that loss of NUP155 function causes AF by altering mRNA and protein transport and link the NPC to cardiovascular disease.
INTRODUCTION
Internal compartmentalization of eukaryotic cells was a critical stage of evolution which enclosed genetic information inside the nucleus and spatially separated it from the rest of the cell (Hoelz and Blobel, 2004) . Transport of macromolecules between the nucleus and cytoplasm is a critical cellular process for eukaryotes which directly affects gene expression and signal transduction (Taddei et al., 2006; Terry et al., 2007) . The nuclear pore complex (NPC) is an evolutionarily conserved structure that spans the nuclear envelope (NE) and mediates bidirectional exchange of macromolecules (mRNAs and proteins) between the nucleus and cytoplasm (Weis, 2003) . The NPC was first recognized in the 1960s, but its role as a mediator of nucleocytoplasmic transport was not definitively demonstrated until 20 years later (Stewart et al., 2007) . The NPC allows for the passive diffusion of molecules of relative molecular mass of 40,000, but actively transports large macromolecules, such as proteins, RNAs, and ribonucleoprotein particles, through shuttling transport receptors (Gorlich and Kutay, 1999) . The NPC is composed of some 30 different nucleoporins that are each present in multiple copies. Extensive electron microscopy and tomography studies in addition to an innovative strategy involving biophysics, proteomics, and sophisticated computation has revealed the general morphology of the NPC (Alber et al., 2007a (Alber et al., , 2007b Beck et al., 2004; Hinshaw et al., 1992) . The overall shape and architecture of the NPC is conserved from yeast to higher eukaryotes.
Nucleoporins are the critical molecular components for the assembly and function of the NPC. NUP155 is a nucleoporin with a calculated molecular mass of about 155 kDa and is a major component of the NPC (Zhang et al., 1999) . The first NUP155 gene was cloned from the rat by Radu et al. in 1993, and was shown to be associated with both nucleoplasmic and cytoplasmic aspects of the NPC (Radu et al., 1993) . Nevertheless, the in vivo physiological roles of NUP155 in mammalian systems are unknown. In this study, we employed both human genetic and mouse gene-targeting approaches to demonstrate the essential roles of NUP155 in cardiac physiology and further link it to the most common clinical cardiac arrhythmia, atrial fibrillation (AF), and early sudden death.
AF is a cardiac disorder characterized by supraventricular tachyarrhythmia due to uncoordinated atrial activation, a rapid atrial rate of 150-300 beats/min, absence of P waves, presence of rapid oscillations or fibrillatory waves (f waves), and inconsistent R-R intervals on electrocardiograms (ECG) (Fuster et al., 2001) . The prevalence of AF is increasing rapidly as the population ages, and reaches more than 8% for people aged 80-89 years (Peters et al., 2002) . More than 15% of strokes are caused by AF (Fuster et al., 2001; Peters et al., 2002) . AF is also associated with worsening heart failure and increased mortality (Savelieva and John, 2004) . Common AF is a complex disease, and its pathogenesis involves multiple genetic factors, environmental factors, and interactions among these factors. Nearly 30% of AF patients present with either an autosomal dominant or recessive familial history (Oberti et al., 2004; Wang, 2008) . Although rare mu- (A) Genotyping results are shown for an affected member (boxed VI:3), a newly born male in the arAF1 family, together with the results for other family members reported previously (Oberti et al., 2004) . The new affected male patient, VI:3, was genotyped with five linked markers at the arAF1 locus, including D5S493, D5S426, D5S455, D5S1998, and D5S1964. Affected individuals are shown as filled squares (males) and circles (females); normal individuals are indicated by empty symbols; obligate heterozygous carriers are shown with dots in symbols; deceased family members are shown with slashes (/); the proband is indicated by an arrow. (B) Multipoint LOD score analysis. Genotypes at D5S1506, D5S426, D5S493, D5S455, D5S1998, D5S1964, and D5S1490 were used to determine multipoint LOD scores at chromosome 5p13. D5S1506 was arbitrarily plotted at 0 cM at the abscissa. Other microsatellite markers near the arAF1 locus are indicated along the abscissa from telomere to centromere. Multipoint LOD scores were plotted on the ordinate. tations in ion channels have been identified in a few families with AF, the genetic basis for the majority of AF cases remains largely unknown (Wang, 2008) . We have previously reported a large AF family with an autosomal recessive inheritance pattern and identified the first genetic locus for autosomal recessive AF to chromosome 5p13 (arAF1) (Oberti et al., 2004) .
In this study, we provide evidence demonstrating that the AF gene at the 5p13 arAF1 locus is the NUP155 gene. The results provide a novel non-ion-channel mechanism for the pathogenesis of AF and, to our knowledge, link the NPC to cardiovascular disease for the first time.
RESULTS

Genetic Linkage of Autosomal
Recessive AF to Chromosome 5p13 in the Expanded arAF1 Family and Fine Mapping We previously mapped an autosomal recessive AF locus to chromosome 5p13 in a large arAF1 family (Oberti et al., 2004) . After the initial publication, a new affected male was born (individual VI:3; Figure 1A ). This patient was genotyped with five markers linked to AF at the arAF1 locus, D5S493, D5S426, D5S455, D5S1998, and D5S1964, and was linked to all five. The maximum two-point logarithm of the odds (LOD) score, at a recombination fraction of 0, increased from the previous 3.05 to 4.04 in the expanded pedigree (see Table S1 available online). The maximum multipoint LOD score increased from 4.10 to 4.40 ( Figure 1B) . These results strengthen a linkage of AF to chromosome 5p13.
Fine mapping, with single-nucleotide polymorphisms (SNPs) in the region, restricted the 5p13 AF locus between the NPR3 gene (physical location, 32,747,422) and PTGER4 (physical location, 40,729,594) . A systematic mutational analysis was initiated to identify the AF gene by direct DNA sequence analysis. On the right side of the AF locus, sequence analysis of OSMR, FYB, and FLJ39155 (now known as EGFLAM; physical location, 38,501,338) identified an SNP in EGFLAM that showed a recombination event with AF in the family, further defining the AF locus within a 5.75 Mb interval.
A Missense Mutation in NUP155 Cosegregates with AF in the arAF1 Family We systematically analyzed almost all the known and putative genes within the refined arAF1 locus (not including the known disease-causing genes, SMN1 and SMN2, for amyotrophic lateral sclerosis and spinal muscular atrophy, GDNF for Hirsch Sprung disease, and NIPBL for Cornelia de Lane syndrome). All exons and exon-intron boundaries of the regional candidate genes were sequenced in two DNA samples, one from the affected individual V-11 ( Figure 1A ) and the other from a normal control individual. The only mutation identified was a homozygous mutation, R391H, in the nucleoporin 155 gene (NUP155) (Figure 2A ). The R391H mutation occurs in exon 11 at an evolutionarily, highly conserved arginine (R) residue ( Figure 2B ). In addition, 1700 control individuals did not carry the mutation (data not shown). All affected members of the arAF1 family carried the homozygous R391H mutation, whereas all obligate carriers carried the heterozygous mutation. All normal family members were mutation negative (Figure 3 ). These results provide strong direct genetic evidence that the R391H is a pathogenic mutation that causes AF in the family.
Mutation R391H Affects Nuclear Envelope Localization of NUP155 Protein and Nuclear Envelope Permeability We hypothesized that incorrect NE localization of NUP155, mediated by the R391H mutation, is a mechanism for the pathogenesis of AF. To test the hypothesis, we evaluated the nuclear localization of wild-type (WT) and R391H mutant NUP155 proteins in COS7 cells. COS7 cells were transiently transfected with mammalian expression constructs for enhanced green fluorescent protein (EGFP) -tagged WT or R391H mutant NUP155 proteins. Wild-type NUP155 protein localized, in a strong, tight, and punctuated manner with many NE foci (Figure 4A ). In contrast, R391H mutant NUP155 protein failed to visibly accumulate at various NE foci and was diffusely distributed toward and in the cytoplasm. Identical results were obtained by immunostaining studies of COS7 cells transfected with either Flag-tagged WT or R391H mutant NUP155 constructs (Figure 4B) . These results suggest that the R391H mutation in NUP155 affects the targeting of NUP155 protein to specific sites (presumably the NPC) on the NE. The functional effect of the R391H mutation was tested by a newly developed assay for NE permeability (Grote and Ferrando-May, 2006 Figures 4C and 4D ). The R391H mutation may act by a loss-of-function mechanism consistent with the common mechanism of most recessive human diseases.
Are Associated with AF To further strengthen the link between NUP155 and AF, we developed a knockout mouse line targeting NUP155 by the (B) The R391H mutation is located in exon 11 and occurs at an arginine (R) residue that is highly evolutionarily conserved.
gene-trapping strategy. The trapping vector was inserted in intron 5 of the mouse NUP155 gene, which results in a truncated mNUP155 protein of only 217 amino acids (the normal NUP155 contains 1391 amino acids) ( Figure 5A ). Homozygous NUP155 À/À mice died during embryogenesis before embryonic day 8.5, whereas heterozygous NUP155 +/À mice were viable. Semiquantitative RT-PCR and western blot analyses showed that the expression levels of mouse NUP155 mRNA and protein were significantly reduced by about 50% in heterozygous NUP155 +/À knockout mice compared with wildtype littermate control mice (Figures 5B and 5C) . This result was confirmed using immunostaining with an anti-NUP155 antibody ( Figure 5D ). The immunostaining study also demonstrated that NUP155 was strongly expressed in atrial myocytes ( Figure 5D ). Continuous telemetry ECG recordings from conscious, freely moving mice revealed significant similarities in cardiac phenotype between human AF patients and NUP155 +/À mice ( Figure 6 ). The observed AF phenotype can sustain for 10 min or longer. The main AF-related phenotypes include (1) absence of discrete P waves, and (2) irregular R-R intervals ( Figure 6 ). These results indicate that downregulation of NUP155 expression by haploinsufficiency (50%) causes AF in mice.
Mutant NUP155 Reduces Atrial Action Potential Duration and Inhibits Export of Hsp70 mRNA and Nuclear Import of Hsp70 Protein Histological analysis of NUP155 +/À knockout mice did not reveal any overt structural abnormalities in heart and skeletal muscle (data not shown), the two organs demonstrating the highest expression levels of NUP155 (Zhang et al., 1999) . Immunostaining with cardiac-specific a-actinin of NUP155 +/À hearts did not reveal obvious differences in the morphology of cardiomyocytes and the atrial tissue architecture ( Figure 7A ). We then examined NUP155 +/À atrial myocytes for electrophysiological alternations.
Compared to NUP155
+/+ cells, atrial myocytes from NUP155 +/À mice showed significantly shortened action potential duration ( Figure 7B ), which is involved in induction and maintenance of AF (Nattel, 1999; Van Wagoner and Nerbonne, 2000) .
To identify a molecular mechanism by which mutant NUP155 causes AF, we tested the hypothesis that NUP155 mutation R391H or the reduction of NUP155 may affect mRNA export of Hsp70. Export of Hsp70 mRNA is inhibited by siRNA knockdown of expression of hCG1, which forms a complex with NUP155 and hGle1 (Kendirgi et al., 2005) . RT-PCR showed that HeLa cells with transient expression of wild-type NUP155 increased export of Hsp70 mRNA, but cells with mutant NUP155 exhibited significant reduction of mRNA export ( Figure 7C ). Similarly, cardiomyocytes from NUP155 +/À mice showed significantly reduced export of Hsp70 mRNA compared to those from NUP155 +/+ mice ( Figure 7D ). These results demonstrate that NUP155 dysfunction significantly inhibits export of Hsp70 mRNA to the cytoplasm. Immunostaining with an anti-Hsp70 antibody showed that overall expression levels of Hsp70 protein were reduced in HeLa cells with transient expression of mutant NUP155 protein ( Figure 7C ) or in NUP155 +/À myocytes (Figure 7D) , consistent with the results of reduced export of Hsp70 mRNA from RT-PCR analysis. Interestingly, nuclear import of Hsp70 protein was also inhibited in HeLa cells with transient expression of mutant NUP155 protein ( Figure 7C ) or in NUP155 +/À myocytes ( Figure 7D ). Similar studies were carried out for Hsp27, but no significant abnormalities in either mRNA export or protein nuclear import were detected (data not shown).
DISCUSSION
Our studies in both humans and mice provide strong evidence for the role of a nucleoporin, NUP155, in the physiology of the heart and the pathogenesis of AF, the most common clinical cardiac arrhythmia. Multiple lines of evidence indicate that NUP155 is the AF gene on chromosome 5p13. First, we identified significant genetic linkage between markers flanking NUP155 and AF in a large family with single and multipoint LOD scores of 4.04 and 4.40, respectively. Second, we identified a novel homozygous mutation, R391H in NUP155, that cosegregates with AF in the AF family, but does not exist in 1700 controls. Third, we demonstrated that the R391H mutation affects the NE localization of NUP155 and reduces NE permeability. Fourth, we demonstrated strong expression of NUP155 protein in atrial myocytes. Finally, heterozygous NUP155 +/À knockout mice showed the AF phenotype, which supports the conclusion that NUP155 is a disease-causing gene for AF. Additional evidence supports a role of NUP155 in the pathogenesis of AF. The human NUP155 gene was reported to display a tissue-specific expression pattern (Zhang et al., 1999) . Northern blot analysis identified a 5.4 kb transcript that showed the highest expression level in two organs, the heart and skeletal muscle (Zhang et al., 1999) . Immunostaining studies also demonstrated strong expression of NUP155 in isolated atrial myocytes ( Figure 5 ). These results are consistent with our conclusion that defects in NUP155 are associated with AF and provide an explanation as to why the heart is the major organ affected by the loss of function of an essential nucleoporin gene, such as NUP155.
To date, our understanding of the genetic basis of AF is mostly limited to genes encoding ion channels. Rare mutations associated with AF have been reported in genes encoding potassium channels, and somatic mutations in the GJA5 gene encoding connexin40 were identified in tissues from three sporadic AF patients (Wang, 2008) . However, the genetic basis for the majority of AF cases remains largely unknown. Positional cloning, based on genome-wide linkage analysis, in large families is the most effective and convincing approach for identifying disease-caus- The data are shown as mean ± SEM.
ing genes. The initial AF-causing mutation in KCNQ1 was identified by a positional candidate gene approach, whereas other ion-channel genes associated with AF were identified by the candidate gene approach in sporadic patients or small nuclear families (Wang, 2008) . NUP155 is another AF gene identified by a positional cloning approach. Most importantly, results from this study provide a novel nonion-channel mechanism underlying the pathogenesis of AF. After the submission of this manuscript, a heterozygous mutation in the NPPA gene encoding atrial natriuretic peptide was identified in a family with autosomal dominant AF (Hodgson-Zingman et al., 2008) , which provides further support for a non-ion-channel basis of AF.
Our data predict a likely cellular mechanism for the pathogenesis of AF. NUP155 has been demonstrated to interact with an mRNA export factor, Gle1 (Kendirgi et al., 2005; Rayala et al., 2004) . The N-terminal 29 amino acid residues of hGle1 are responsible for the interaction with NUP155 and for the targeting of hGle1 to the NPC (Rayala et al., 2004) . Further studies showed that NUP155, hGle1, and nucleoporin hCG1 form a heterotrimeric complex, and siRNA knockdown of hCG1 expression is associated with inhibition of export of Hsp70 mRNA and nuclear accumulation of Hsp70 mRNA (Kendirgi et al., 2005) . Based on these results, we predict that NUP155 deficiency may cause molecular remodeling of gene expression by affecting mRNA export of key atrial genes from the nucleus to the cytoplasm. Thus, NUP155 may act as a key upstream gene that causes AF by regulating the expression of downstream genes by controlling mRNA nucleocytoplasmic export. The specific downstream target genes of NUP155, in the atria, remain to be identified. However, Hsp70 may be an interesting candidate gene. Indeed, the R391H NUP155 mutation and the reduction of NUP155 in heterozygous mice inhibit export of Hsp70 mRNA and nuclear import of Hsp70 protein (Figure 7) . Multiple reports link Hsp70 to AF. Patients with high Hsp70 expression levels have a lower incidence of postoperative AF (Kampinga et al., 2007; Mandal et al., 2005; St. Rammos et al., 2002 ). An M439T substitution in Hsp70 was associated with an increased risk of postoperative AF (Afzal et al., 2008) . Cardiomyocytes from Hsp70 knockout mice exhibit delayed calcium transient decline and reduced sarcoplasmic reticulum calcium content (Kim et al., 2006 ). An abnormality in intracellular Ca 2+ homeostasis may be associated with AF (Chou et al., 2008) . Heat shock proteins such as Hsp70 play important roles in protein folding, trafficking, and cell signaling. We propose that NUP155 may indirectly modulate maturation and trafficking of calcium handling proteins and ion channels through regulation of mRNA and protein transport of Hsp70 or other important atrial proteins, which may provide an explanation for our finding that the action potential duration from NUP155 +/À atrial myocytes is shorter than that from control NUP155 +/+ cells ( Figure 7B ).
The function of NUP155 has been explored with a variety of biochemical and cell biological approaches. The human and mouse NUP155 genes were cloned by Zhang et al. in 1999 , respectively (Zhang et al., 1999 . NUP155 is evolutionarily conserved from yeast, Arabidopsis, Caenorhabditis elegans, Drosophila, mice, and rats to humans. Immunodepletion and siRNA studies, in C. elegans embryos and Xenopus laevis egg extracts, indicated that NUP155 has an essential function in the formation of the NE (Franz et al., 2005) . The results in this study indicate that NUP155 is involved in both export of Hsp70 mRNA and nuclear import of Hsp70 protein. However, the in vivo physiological roles of NUP155 in mammalian systems are unknown. Here we generated a knockout mouse line targeted to NUP155. Homozygous NUP155 À/À mice died before E8.5, suggesting that NUP155 is essential for embryogenesis. Heterozygous NUP155 +/À mice showed an interesting phenotype of AF, the most common clinical cardiac arrhythmia. The mouse data were further extrapolated with genetic studies of human patients showing association of NUP155 with AF. These results reveal a novel role for NUP155 in cardiac physiology and link the NPC to cardiovascular disease. NUP155 deficiency may affect the formation of the NE, and delay or block mitosis, which may reduce myocyte survival. In the long run, myocyte apoptosis and cardiac fibrosis may occur, creating substrate for the initiation and maintenance of AF (Ehrlich et al., 2008) . The mean averages from each cell (n = 12 cells; 3 mice total for each group) were then pooled together for a group average and summarized.
(C) Analyses of export of Hsp70 mRNA and import of Hsp70 protein in HeLa cells transiently transfected using wild-type (WT) or mutant (MT) NUP155 expression plasmids. Cells without transfection were used as a control. Forty-eight hours after transfection, cells were heat shocked for 2.5 hr, and total RNA from nuclear and cytoplasmic fractions was isolated and reverse transcribed with an oligo(dT) 15 primer. Quantitative real time RT-PCR analysis was then used to estimate the levels of Hsp70 mRNA in the cytoplasm and nucleus (left panel). All the samples were analyzed in triplicate and the results were replicated in three independent experiments. The heat-shocked cells were stained with an anti-Hsp70 antibody (red) and DAPI for nuclei (blue) (middle panel). Fluorescence intensity in the whole cell or in the nucleus alone was quantified and is shown as a graph (right panel). n, number of images analyzed.
Clinical findings associated with the NUP155 mutation is of particular interest, as NUP155 mutation carriers were associated with a presentation of in utero and neonatal AF as well as early sudden death (Oberti et al., 2004) . The proband (V:11) and AF patients V:9, V:10, and VI:1 ( Figure 1A ) all died suddenly at the age of 15, 3, 3, and 18 months, respectively. The sole survivor, at the time of the prior publication (Oberti et al., 2004) , AF patient VI:2 ( Figure 1A) , died recently at the age of 20 months. The early deaths in the family may be related to AF-induced ventricular tachyarrhythmias and nonischemic cardiomyopathies (Knight, 2003; Shinbane et al., 1997) .
In humans, only homozygous carriers with mutation R391H were affected with AF, whereas heterozygous carriers were asymptomatic. On the other hand, heterozygous NUP155 +/À mice developed AF. This may be due to a possibility that the R391H mutant NUP155 allele is a weaker mutation than haploinsufficiency. The R391H mutant NUP155 protein may retain some residual nucleoporin activity, and causes AF in the human, only when it is in the homozygous state. Future studies are needed to clarify this issue.
Laramie et al. identified a putative locus that influences resting heart rate, with suggestive evidence of linkage to markers on chromosome 5p13 (LOD score of 1.96) (Laramie et al., 2006) which overlaps with our 5p13 AF locus. It is also interesting to note that heterozygous NUP155 +/À mice show a variable heart rate ( Figure 6 ). It is possible that NUP155 variants will also be associated with variation of the human resting heart rate.
In conclusion, our findings identify a novel molecular, non-ionchannel determinant for AF, and extend the understanding of the nuclear pore complex to cardiovascular physiology. To our best knowledge, this study is the first to link a nucleoporin defect to cardiovascular disease. The molecular identification of NUP155 as an AF gene may facilitate the development of new diagnostic and therapeutic tools for prevention and treatment of AF.
EXPERIMENTAL PROCEDURES Study Subjects and Linkage Analysis
Study subjects involved were enrolled as described previously (Oberti et al., 2004) . The new patient VI:3 ( Figure 1A ) was born on February 14, 2007 with AF and atrial tachycardia. The patient is currently in sinus rhythm and on propahenol, propranolo, and aspirin. This study was approved by the Cleveland Clinic Institutional Review Boards on Human Subject Research and informed written consent was obtained for each study subject. Whole blood (10-20 ml) was obtained from each subject and human genomic DNA was isolated from the whole blood using the DNA isolation kit for mammalian blood (Roche Diagnostic).
Genotyping of polymorphic microsatellite markers was carried out as described previously (Wang et al., 1995 (Wang et al., , 1996 . Phenotyping data, genotyping data, and pedigree information were used for pairwise linkage analysis using the Fastlink software package (Cottingham et al., 1993) . Single-point and multipoint linkage analyses were performed assuming an autosomal recessive pattern of inheritance, a disease-allele frequency of 0.001, and penetrance of 0 for carriers and noncarriers and 0.99 for homozygous affected individuals.
Logarithm of the odds (LOD) scores were calculated as described previously (Oberti et al., 2004) .
Mutational Analysis
Mutation screening was carried out using direct DNA sequence analysis. All exons and exon-intron boundaries of each candidate gene were PCR amplified. The PCR products were purified using the PCR purification kit (QIAGEN) and subjected to DNA sequencing analysis using both forward and reverse primers using the ABI BigDye Terminator Cycle Sequencing kit v1.1 with an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems).
Cell Culture and Immunostaining COS7 cells were maintained in Dulbecco's minimum essential media (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen). Transfection of COS7 cells (10 6 cells) was carried out with 2 mg of each mammalian expression construct for NUP155, including p3xFlag-WT-NUP155 and p3xFlag mutant-NUP155 using Lipofectamine 2000 (Invitrogen). Cells were plated on coverslips in a 10 cm plate for 12 hr before the transfection. Fortyeight hours after the transfection, immunostaining was carried out with the M2 anti-FLAG monoclonal antibody (Sigma) as the primary antibody and a FITC-conjugated anti-mouse antibody (Sigma) as the secondary antibody. Cells in coverslips were fixed in 4% paraformaldehyde/PBS for 15 min at room temperature, treated with 0.5% Triton X-100, and then blocked in 5% milk in PBS + Tween 20 (PBST) for 1 hr. The coverslips were then incubated with the M2 anti-FLAG monoclonal antibody (1:1000 dilution in 5% milk in PBST) for 12 hr at 4 C, washed with PBST, and incubated with the secondary FITC-conjugated anti-mouse antibody (1:1000 dilution in 5% milk in PBST) for 1 hr at room temperature. Then, 1-2 drops of Vectashield containing 4 0 ,6-diamidino-2-phenylindole (DAPI) was added and the coverslips were placed on the slides, sealed with nail oil, air-dried, and analyzed under an IX81 motorized inverted research fluorescence microscope (Olympus). COS7 cells were also transfected with expression constructs for EGFPtagged NUP155, pEGFP-WT-NUP155, or pEGFP mutant-NUP155 as described above. The cells on the coverslips were examined directly under an IX81 motorized inverted research fluorescence microscope (Olympus).
Quantitative RT-PCR Analysis
Total RNA was prepared from heart tissue of the heterozygous NUP155 knockout and wild-type mice. Total RNA was then isolated using the TRIzol reagent (Invitrogen). Double-stranded complementary DNA (ds-cDNA) was synthesized from 16 mg of total RNA using Stratagene's RT-PCR kit. For semiquantitative RT-PCR, we designed the primers to amplify exons 23 and 24 of the mouse NUP155 gene. The forward primer is 5 0 -GAA TTT CAA GAG CAG CTG AAG ATC A-3 0 and the reverse primer is 5 0 -CTT GCC TAT ACT GAG CAC AGA CAC-3 0 . 18S rRNA primers were used as an internal control (Tian et al., 2004a) . The number of cycles for PCR was optimized for each sample to obtain data in the linear range for quantification. The PCR profile was 25 cycles (for NUP155) or 18 cycles (for the 18S RNA) of denaturation (94 C for 30 s), annealing (55 C for 30 s), and extension (72 C for 1 min) and a final extension step of 10 min at 72 C. The PCR products were separated on a 1% agarose gel.
Western Blot Analysis
Western blot analysis was carried out with an anti-NUP155 antibody raised against C-terminal residues (VQAITGNFKSLQAKLERLH; a kind gift from S.R. Wente; Kendirgi et al., 2005) . (HTZ) mice. Neonatal myocytes were heat shocked for 2.5 and 3.5 hr for RT-PCR analysis or 2.5 hr for immunostaining and analyzed as described in (C). Green signal, Hsp70 protein; blue signal, DAPI staining for nuclei; n, number of mice used for the assay. The data are shown as mean ± SEM. database (http://baygenomics.ucsf.edu/). The ES cell line was recovered and resequenced to confirm its identity. The Bay Genomics/University of California, Davis facility performed blastocyst injection of the ES cells, which yielded 13 chimeras (11 males and 2 females) and successful germline transmission.
Isolation of Mouse Atrial Myocytes, Measurements of Action Potential Duration, and Immunocytochemistry
The procedures for isolation of atrial myocytes from mice were modified from Rose et al. (2004) , and detailed protocols are included in Supplemental Data. The action potential duration of isolated atrial myocytes was measured as described previously (Tian et al., 2004b; Yong et al., 2007) . Isolated atrial myocytes were seeded onto carbon-coated glass coverslips and washed with PBS (pH 7.4) (Sigma). The myocytes were fixed in 10% neutral buffered formalin (Sigma) for 15 min, washed three times with PBS, and permeabilized by incubation in PBS containing 0.1 Triton X-100 for 10 min. After washing three times with PBS, the myocytes were blocked in 10% normal goat serum (NGS; Sigma) in PBS for 60 min, and incubated with a 1:100 concentration of the anti-NUP155 antibody diluted with PBS containing 1% BSA and 10% NDS in a humid box at À4 C overnight. After washing three times with PBS, the myocytes were incubated with goat anti-rabbit IgG conjugated to FITC (Sigma) in a humid box at room temperature in the dark for 1 hr. After washing three times with PBS, the myocytes were mounted with Vectashield mounting media (Vector Labs), sealed with nail polish, and visualized using an epifluorescent microscope (BX61; Olympus). The mean intensity of the protein signal in a myocyte was measured using Image Pro 6.1 (Media Cybernetics). Adobe Photoshop CS and Illustrator CS (Adobe Systems) were used for processing images.
Mouse ECG Recordings ECG recordings in mice were carried out as described previously (Tian et al., 2004b; Zhang et al., 2007) . Mice (5-10 months, 30-35 g) were anesthetized with 0.015 ml/g body weight Avertin (2.5%; Sigma-Aldrich). TA10ETA-F20 transmitters (Data Sciences International) were surgically implanted into the peritoneal cavity of the NUP155 +/À mice. Nontransgenic littermates (NUP155
+/+
) were used as controls. After the surgery, the mice were allowed to recover for 1 week prior to recording of ECG. The Data Sciences telemetry system was used to continuously monitor and record ECG of conscious, unrestrained mice using Data Sciences data acquisition ECG software and saved on a hard disk for later analysis. Signals below 248 MHz were filtered out.
Nuclear Envelope Permeability Assays
The permeability of the nuclear envelope was measured using a newly developed assay as described (Grote and Ferrando-May, 2006) . In brief, cells on coverslips (15,000 cells/coverslip) were permeabilized using a low concentration of digitonin (6 mg/ml). These semipermeabilized cells retained the intact nuclear membrane. The cells were incubated with cytosolic S-20 extract and a fluorescent reporter, 70 kDa Texas red-labeled dextran (Molecular Probes). Cells were then visualized under a microscope. Images were taken and fluorescence intensity in the nuclei was quantified using Image Pro 6.1 (Media Cybernetics).
Assays for Export of Hsp70 mRNA and Nuclear Import of Hsp70 Protein Export of Hsp70 mRNA was assayed using RT-PCR analysis of cytoplasmic and nuclear RNA as described (Kendirgi et al., 2005) . The RT-PCR data were analyzed as described (Pfaffl, 2001) . Details are in Supplemental Data.
Nuclear import of Hsp70 protein was measured using immunostaining analyses as previously described (Zeng et al., 2004) . A mouse monoclonal antibody (Assay Designs, no. SPA-810) was used for a nuclear import assay in HeLa cells, and a rabbit polyclonal antibody (Assay Designs, no. SPA-812) was used for the assay in mouse neonatal myocytes.
Statistical Analysis
Data are shown as mean values ± SEM. Statistical analysis was performed using ANOVA and two-tailed Student's t tests to compare means, and significance was set at the p value of < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include one table and Supplemental Experimental Procedures and can be found with this article online at http://www.cell.com/ supplemental/S0092-8674(08)01314-7.
